Abstract
New linear and cyclic guanidines were synthesized and tested in vitro for their antifungal activity toward clinically relevant strains of Candida species, in comparison to fluconazole. Macrocyclic compounds showed a minimum inhibitory concentration in the micromolar range and a biological activity profile in some cases better than that of fluconazole. One macrocyclic derivative was also tested against Aspergillus species and showed high antifungal activity comparable to that of amphotericin B and itraconazole.
| Original language | English |
|---|---|
| Pages (from-to) | 7376-7379 |
| Journal | Journal of Medicinal Chemistry |
| Volume | 52 |
| Issue number | 23 |
| DOIs | |
| Publication status | Published - 2009 |